AUS
NZ
UK
CA
USA
IND
Healthcare
Orthocell's Path to Growth: Record Revenue and Global Expansion Plans
November 29, 2024 01:59 PM AEDT| By Team Kalkine MediaHighlights,Orthocell,(OCC) reports a 30% annual revenue growth with strong product performance,.,Remplir,™ poised for launch in the US, targeting the,$1.6 billion,nerve repair market,.,Robust financial health with zero debt and strategic global expan...
Tryptamine (ASX:TYP) Completes Psilocin Study in Obesity
November 29, 2024 12:45 PM AEDT| By Team Kalkine MediaHighlights,Tryptamine Therapeutics concludes Phase 1b study of TRP-8803 in obese participants,.,Study provides insights for Phase 2 development with a focus on dose optimization,.,Final results,anticipated,to guide future trials addressing diverse he...
Pacific Smiles Group Revamps Board Amid Genesis Bidco's Leadership Transition
November 29, 2024 11:54 AM AEDT| By Team Kalkine MediaHighlights,Pacific Smiles Group announces significant board restructuring,.,Genesis Bidco holds majority voting power and extends acquisition offer,.,Leadership changes,set,for December, with new appointees from Genesis Bidco,.,Pacific Smiles Group (...
Morningstar Ups Pro Medicus Valuation After Major Contract Win
November 29, 2024 11:32 AM AEDT| By Team Kalkine MediaHighlights,Valuation Boost:,Morningstar raises Pro Medicus' fair value estimate by 8% to AU$43 per share.,Revenue Growth:,FY26 revenue forecast increased to AU$275 million, reflecting a key Trinity Health contract.,Stock Surge:,Pro Medicus shares hav...
CSL Share Price Struggles in 2024 but Analysts Predict a Strong Rebound
November 29, 2024 11:20 AM AEDT| By Team Kalkine MediaHighlights,Underperformance in 2024:,CSL shares fell 3% compared to a 10% rise in the ASX 200 index.,Analyst Optimism:,Bell Potter forecasts a 17% upside, targeting a price of $345.00.,Growth Catalysts:,Margin recovery and strong performance from CSL...
Algorae Pharmaceuticals Appoints Dr. Sarah Siggins to Scientific Advisory Board
November 28, 2024 04:07 PM AEDT| By Team Kalkine MediaHighlights,New Appointment:,Dr. Sarah Siggins joins Algorae’s scientific advisory board, bringing 14 years of pharmaceutical expertise.,AI Drug Discovery:,Algorae’s AI platform delivers 24 drug targets for oncology indications, progressing to preclin...
Strategic Moves Lead to Expansion of Resonance Health’s Global Reach
November 28, 2024 03:57 PM AEDT| By Team Kalkine MediaHighlights:,Resonance Health Ltd (ASX:RHT) has strengthened its position in healthcare technology with its Software-as-a-Medical Device (SaMD) and clinical trial services, utilized in over 400 locations worldwide.,The company’s acquisition of TrialsW...
Fisher & Paykel Healthcare, Humm, Novonix, and Webjet Shares Experience Setback
November 28, 2024 03:37 PM AEDT| By Team Kalkine MediaHighlights:,Fisher & Paykel Healthcare shares are down 1.5% after its half-year results, with no guidance upgrade for FY 2025.,Humm Group’s share price has dropped 17% following weak guidance and concerns over economic pressures.,Webjet faces a 4% de...
Pro Medicus Secures Major 10-Year Contract with Trinity Health
November 28, 2024 03:02 PM AEDT| By Team Kalkine MediaHighlights,Pro Medicus announces a significant $330 million contract with Trinity Health,.,The 10-year deal includes migrating systems to the Visage 7 platform,.,Shares of Pro Medicus saw a strong uptick following the announcement,.,Pro Medicus (ASX:...
Chimeric Therapeutics Gains Financial Boost with R&D Rebate
November 28, 2024 02:57 PM AEDT| By Team Kalkine MediaHighlights,Chimeric Therapeutics (CHM) secures $4.17M R&D tax rebate,.,Funds boost cash reserves, strengthening research potential,.,Focus,remains,on advancing cell therapy for blood cancer,.,Chimeric Therapeutics (ASX:CHM), a biotechnology company s...
Can Filamon’s Innovative Drug ALPHA-003 Redefine Dementia Treatment?
November 28, 2024 02:43 PM AEDT| By Team Kalkine MediaHighlights,Filamon’s ALPHA-003 drug discovery offers a more efficient approach to the treatment of dementia.,Unlike current dementia treatments that focus on minimising damage after it has already happened, ALPHA-003 aims to protect brain cells from...
Lumos Diagnostics Holdings (ASX:LDX): Challenges Amid Declining Revenue Trends
November 28, 2024 12:18 PM AEDT| By Team Kalkine MediaHighlights,Lumos Diagnostics shares dropped significantly in the past month,.,The company’s P/S ratio reflects contrasting industry performance,.,Shrinking revenues raise questions about long-term growth prospects,.,Shares of Lumos Diagnostics Holdin...
Algorae Pharmaceuticals Welcomes Dr. Sarah Siggins to Advisory Board
November 28, 2024 11:29 AM AEDT| By Team Kalkine MediaHighlights,Algorae,Pharmaceuticals appoints Dr. Sarah Siggins to its scientific advisory board,.,AI-driven drug discovery platform yields promising oncology targets,.,Strategic focus on innovation and collaboration under Dr. Siggins’ guidance,.,Algor...
Aroa Biosurgery (ASX:ARX) Shares Gain After Interim Results
November 28, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights,Aroa Biosurgery reports steady revenue growth with industry-leading projections.,Forecasts suggest improved revenue trends but higher projected losses.,Analysts,maintain,a stable outlook with minimal changes to price targets.,Aroa Biosurge...
Imricor Conducts First Atrial Flutter Ablation Procedure at Swiss Healthcare Facility
November 27, 2024 04:04 PM AEDT| By Team Kalkine MediaHighlights:,Imricor Medical Systems performs its first iCMR ablation procedure at Lausanne University Hospital (CHUV), Switzerland.,CHUV becomes Imricor's first customer site in Switzerland and the third site in the VISABL-AFL clinical trial.,The iCM...
PYC Therapeutics Advances New Kidney Disease Drug to Human Trials
November 27, 2024 03:50 PM AEDT| By Team Kalkine MediaHighlights:,PYC Therapeutics advances its investigational drug, PYC-003, into human clinical trials for Autosomal Dominant Polycystic Kidney Disease (PKD).,Pre-clinical studies have demonstrated safety, efficacy, and targeted delivery of the drug in...
Pro Medicus, Technology One, Wisetech, and Xero See Rising Valuations on ASX
November 27, 2024 03:47 PM AEDT| By Team Kalkine MediaHighlights:,ASX technology stocks like Pro Medicus, Technology One, Wisetech Global, and Xero have seen substantial share price growth in 2024.,The S&P/ASX 200 Information Technology sector has outperformed all other sectors in the last 12 months.,A...
Dengue Trial Breakthrough: Island Pharma Advances to Phase 2b with FDA Backing
November 27, 2024 02:34 PM AEDT| By Team Kalkine MediaHighlights,Island Pharma progresses anti-dengue drug ISLA-101 to Phase 2b trials in early 2025,.,No safety concerns reported during Phase 2a trial, clearing the way for,next,stage,.,Study focuses on controlled dengue transmission for consistent resul...
Cleo Diagnostics Advances Ovarian Cancer Detection Trials
November 27, 2024 01:27 PM AEDT| By Team Kalkine MediaHighlights,Cleo Diagnostics adds Royal Women’s Hospital in Melbourne to its trial network,.,U.S. trials are progressing toward an FDA submission slated for 2025,.,The trial aims to enhance early detection and better health outcomes for women,.,Cleo D...
Pro Medicus Secures $24 Million US Contract, Still Share Price Dip
November 27, 2024 01:18 PM AEDT| By Team Kalkine MediaHighlights,Pro Medicus announces a $24 million, five-year contract extension with NYU Langone Health.,Expansion includes full-stack cloud migration of the institution’s imaging system.,Continued growth in North America with nine new contracts secured...
Advertise your brand on Kalkine Media